August 2021 - Page 2 of 3

WednesdayAug 18, 2021 9:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented Technology Increasing Effectiveness and Potentially Lowering Healthcare Costs

Company’s patented DehydraTECH(TM) technology is showing the potential of reducing healthcare costs by improving oral medication administration – using capsule and pill form over injection administration Lexaria’s offering could potentially offer accelerated regulatory filing with the FDA and other regulators around the world The company sub-licenses its DehydraTECH technology for the delivery of fat-soluble active molecules and drugs while also operating four subsidiary companies Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, recently announced results from an anti-viral drug molecular characterization study performed by the National Research Council (“NRC”). Results confirmed that the drugs tested remained stable and…

MondayAug 16, 2021 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Marks Huge Milestone With The Fulfilment of Its Initial Purchase Order Valued at US$1.1m; Set to Hold First Half 2021 Earnings Call on August 19

Kasa, Flora’s food and beverage division, announced that it had completed its first purchase order valued at approximately US$1.1m This fulfillment is in line with the sales agreement with Tropi, the largest distributor in Colombia, that dates back to July 2021 and is set to last for a year This initial sale demonstrated the company’s ability to follow through with its commitments Flora is also set to hold its earnings call for the first half of the 2021 fiscal year The virtual event is scheduled for Thursday, August 19, 2021, at 4:30 p.m. E.T. Back in July 2021, Flora Growth…

WednesdayAug 11, 2021 12:44 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Partial Results from Human Clinical Trial of DehydraTECH(TM)-Processed Cannabidiol for Hypertension

Clinical study HYPER-H21-1 evaluates the use of patented DehydraTECH(TM)-processed CBD for use against hypertension Hypertension is a primary or contributing factor in the death of almost 500,000 people per year, with approximately one in four adults aged 20 to 44 suffering from high blood pressure Initial results of the study show that blood pressure was reduced in both male and female volunteers, resulting in the reinforcement of pre-existing findings demonstrating that DehydraTECH delivers superior performance Lexaria plans on launching two additional clinical trials, for a total of three clinical trials in 2021 for the DehydraTECH-CBD with hypertension applications Lexaria (NASDAQ:…

TuesdayAug 10, 2021 12:22 pm

Consumer Shift from Alcohol to Cannabis-Infused Beverages Looks to Benefit BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC)

Research shows one in three cannabis users drink less alcohol when compared to before legalization, 84% feel cannabis is safer, nearly half (47%) prefer cannabis over alcohol BevCanna specializes in the production of in-house and white-label cannabis-infused beverages using Canadian premium alkaline spring water BevCanna’s HACCP-certified, 40,000 square foot manufacturing facility operating by GMP standards, current capacity at 210 million bottles per annum Extensive retail network spans 3,000+ points of distribution throughout North America Cannabis-infused beverages are increasing in popularity as the drink of choice for consumers in social settings — a trend that some analysts believe threatens the alcoholic…

TuesdayAug 10, 2021 12:01 pm

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Releases Q4, FY 2020, Q1 2021 Financial Results on the Back of Strong, Sustained Traction for Its Brands

Red White & Bloom released its Q4 2020 and FY 2020 results and later reported its Q1 2021 results In its Q4 2020 results, the company posted a 158% quarter-over-quarter increase in revenue from $CA6.1 million in Q3 2020 to $15.7 million Its FY revenue grew from nil in 2019 to CA$23.3 million in 2020, while its gross profit was CA$13.35 million in 2020 from nil in 2019 RWB reported $32.7 million in Q1 2021 adjusted sales, an increase of 14.5% over Q4 2020 In a statement contained in the company’s December 2020 investor deck presentation, Red White & Bloom…

TuesdayAug 10, 2021 11:38 am

Flora Growth Corp. (NASDAQ: FLGC) Inks 2 LOIs to Boost CBD Product Distribution in Australia, Latin America

Flora Growth Corp. is a Colombian cannabis cultivator that is building a global cannabis CPG portfolio of premium brands and products Flora Growth recently announced an LOI designed to grant it an in-road to Australia’s over-the-counter medical cannabis and CBD commercial markets The company also signed an LOI to distribute popular Canadian pain topical brand KaLaya throughout Latin American countries, with exports planned to the United States, and to infuse its established line of products with CBD Market analysts predict Australia’s medial cannabis market will explode from about $150 million this year to more than a billion dollars by 2025…

MondayAug 09, 2021 2:18 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Subsidiary Inks Deal to Provide Limited-Edition Alkaline Spring Water to BC Firefighters

Naturo Group signs contract with BC Wildfire Services Division; will provide special bottled water to over 1,100 firefighters across British Columbia. TRACE-branded natural 7.7ph alkaline spring water is sourced directly the source in British Columbia, the very land the firefighters protect. BevCanna’s TRACE product line features unique, ancient minerals that offer a broad range of wellness properties including cognitive performance, immune function and gut health. BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) has announced that its wholly owned subsidiary Naturo Group has been selected to manufacture and supply a special, limited-edition run of its TRACE-branded, alkaline spring water to…

MondayAug 09, 2021 1:49 pm

Flora Growth Corp. (NASDAQ: FLGC) Receives Fair Value Estimate, Coverage from Argus Research Company; Developing Growth Opportunities by Columbia’s Cannabis Law, Headquarter Relocation

Flora Growth Corp recently received coverage from Argus Research, which gives the company’s stock a fair value estimate of $7.50 against the $3.24 recorded July 20 Argus also projects that Flora’s revenue would increase to $9 million in 2021 and $31 million in 2022, up from $0.1 million reported in 2020 Flora received a boost in its operations when Colombia’s president accepted and signed reforms to the existing cannabis legislation The updated law allows for the manufacture, sale and export of psychoactive (high-THC) cannabinoid ingestible and medical products and removes marketing limitations on cannabis products in Colombia Flora is also…

MondayAug 09, 2021 1:05 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) and Its Quest to Build an Industry-Leading, Rare Cannabinoid Enterprise

InMed announced a non-binding letter of intent to acquire BayMedica Inc. The move is designed to grow InMed’s market presence and strengthen its operations The two companies have had a reciprocal research collaboration that dates back to November 2020 InMed looks to capitalize on the growing cannabinoid industry that is projected to grow at a CAGR of 21.2% from 2021 to 2028 InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company committed to developing cannabinoid-based pharmaceutical drug candidates. It also manufactures technologies for pharmaceutical-grade rare cannabinoids. It is known for creating a pipeline of cannabinoid-based pharmaceutical drug candidates to treat various…

FridayAug 06, 2021 9:30 am

First Results from Lexaria Bioscience Corp. (NASDAQ: LEXX) Study Show Marked Gains in Blood Pressure Reduction over Generic CBD Controls

Drug delivery platform developer Lexaria Bioscience has developed its patented DehydraTECH(TM) as a means of transforming pharmaceuticals that increases their bioavailability and speed of efficacy Ongoing testing of DehydraTECH in combination with cannabidiol (“CBD”) is analyzing DehydraTECH’s responsiveness to hypertension conditions that are targeted in heart disease and stroke therapies Partial results from the company’s first study indicate Lexaria’s DehydraTECH platform, when processed with CBD, reduces blood pressure and does so much more rapidly when compared with the generic CBD controls The complete results of the study will be produced as sample and data analyses work are completed Lexaria is…

News and publishing service for CBD related companies

Contact us: 303.498.7722

Month: August 2021